Key facts
- It has raised $42.5M across 3 recorded rounds; the latest was Early Stage VC ($25.0M) in Dec 2025.
- Notable investors include 8VC, Bienville Capital, LeFrak, Threshold Ventures, Five Elms Capital — 7 tracked in total.
- Ritten has filed 3 Form Ds with the SEC since 2022, most recently Dec 2025 ($25.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ritten
Funding rounds
3 roundsAbout Ritten
Developer of an electronic medical records platform designed to help addiction treatment providers improve the quality of care they provide to their patients. The company offers customized workflow configurations that help to deliver complex treatment consistently and compliantly, enabling clinicians and administrators to maintain a comprehensive patient record that tracks all aspects of a patient's care, including clinical notes, medications, and treatment plans, and deliver personalized, data-informed care.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2020
- Employees
- 48
- Website
- ritten.io/
- Ownership
- Privately Held (backing)
Ritten doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ritten shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ritten in its N-PORT filings yet. We sweep new filings monthly.